Prestige Consumer Healthcare Inc [PBH] stock is trading at $87.35, up 14.78%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PBH shares have gain 11.39% over the last week, with a monthly amount glided 17.22%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Prestige Consumer Healthcare Inc [NYSE: PBH] stock has seen the most recent analyst activity on December 09, 2024, when Sidoti downgraded its rating to a Neutral but kept the price target unchanged to $90 for it. Previously, DA Davidson upgraded its rating to Buy on June 21, 2024, and elevated its price target to $93. On November 17, 2022, Canaccord Genuity initiated with a Buy rating and assigned a price target of $71 on the stock. Jefferies upgraded its rating to a Buy and increased its price target to $70 on May 10, 2022. Oppenheimer upgraded its rating to a Outperform but $63 remained the price target by the analyst firm on May 09, 2022. DA Davidson downgraded its rating to Neutral for this stock on August 07, 2020. In a note dated June 29, 2020, Sidoti upgraded an Buy rating on this stock.
Prestige Consumer Healthcare Inc [PBH] stock has fluctuated between $60.00 and $86.36 over the past year. Currently, Wall Street analysts expect the stock to reach $86 within the next 12 months. Prestige Consumer Healthcare Inc [NYSE: PBH] shares were valued at $87.35 at the most recent close of the market. An investor can expect a potential drop of -1.55% based on the average PBH price forecast.
Analyzing the PBH fundamentals
Prestige Consumer Healthcare Inc [NYSE:PBH] reported sales of 1.11B for the trailing twelve months, which represents a drop of -0.88%. Gross Profit Margin for this corporation currently stands at 0.54% with Operating Profit Margin at 0.3%, Pretax Profit Margin comes in at 0.25%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.12 and Total Capital is 0.1. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 81.85 points at the first support level, and at 76.36 for the second support level. However, for the 1st resistance point, the stock is sitting at 90.12, and for the 2nd resistance point, it is at 92.89.
Ratios To Look Out For
For context, Prestige Consumer Healthcare Inc’s Current Ratio is 3.56. In addition, the Quick Ratio stands at 2.10 and the Cash Ratio stands at 0.5. Considering the valuation of this stock, the price to sales ratio is 3.89, the price to book ratio is 2.49 and price to earnings (TTM) ratio is 21.28.
Transactions by insiders
Recent insider trading involved Lombardi Ronald M., Chief Executive Officer, that happened on Nov 19 ’24 when 10875.0 shares were sold. Officer, Lombardi Ronald M. completed a deal on Nov 19 ’24 to buy 10875.0 shares. Meanwhile, Chief Executive Officer Lombardi Ronald M. sold 82237.0 shares on Nov 18 ’24.
